Skip to main content
Toggle navigation
Login
Search
Home
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Tagen, Michael
PumasAI
(
S-114
)
A Bayesian Population Pharmacokinetic Analysis of Oritavancin in Pediatric Patients with Skin Infections
Michael Tagen
Favorite
Tang, Fei
Genentech
(
M-053
)
Exploratory population pharmacokinetic analysis of vixarelimab using a two-target quasi-steady-state TMDD model in healthy volunteers and patients with pruritic conditions
Fei Tang
Favorite
Tang, Kayden
Central Bucks HS East
(
T-092
)
Mechanistic Modeling of Bispecific Antibody Combination Therapy to Optimize TumorKilling in Cancer Immunotherapy
Kayden Tang
Favorite
Tang, Zoey
AstraZeneca
(
S-048
)
Exposure-Response Analyses of Dato-DXd in patients with hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer
Zoey Tang
Favorite
Taylor, Zachary
Cincinnati Children's Hospital Medical Center
(
M-070
)
Population pharmacokinetic and exposure-response analysis of high-dose methotrexate-associated mucositis in infant patients with acute lymphoblastic leukemia
Zachary Taylor
Favorite
Thai, Hoai-Thu
Quantitative Pharmacology, Translational Medecine Unit, Sanofi
(
T-099
)
Joint modeling of serum M-protein and PFS to predict response to isatuximab in combination with bortezomib/lenalidomide/dexamethasone in newly diagnosed multiple myeloma patients
Hoai-Thu Thai
Favorite
Thalluri, Bhargavi
The University if Tennessee Health Science Center
(
T-081
)
A Population PK Approach to Evaluate Plasma and ELF Exposure Changes Following Co-administration of Spectinamide 1599 and Pyrazinamide in Mice
Bhargavi Thalluri
Favorite
Thiagarajan, Kannan
Vantage Research LLC
(
M-011
)
Quantitative Systems Pharmacology (QSP) Modeling of efficacy and nausea of GLP-1 mono and dual (GLP-1/GIP) receptor agonists (RA) to support weight management and glycemic control in obese patients
Kannan Thiagarajan
Favorite
(
S-018
)
Evaluating antibody drug conjugate (ADC) combinations using the platform Quantitative Systems Pharmacology (QSP) model
Kannan Thiagarajan
Favorite
(
T-009
)
Bridging Preclinical Data and Human Dose Selection for ADCs: Lessons from Approved Molecules
Kannan Thiagarajan
Favorite
Tirucherai, Giridhar
Scholar Rock, Inc.
(
T-082
)
Population PK and PK/PD Modeling of Apitegromab in Spinal Muscular Atrophy Patients
Giridhar Tirucherai
Favorite
Tobin, Kevin
University of Maryland
(
T-108
)
Right Dose, Wrong Patient? Clinical Perspectives on Atomoxetine Nonresponse in ADHD
Kevin Tobin
Favorite
Tong, Dominic
InsightRX
(
T-112
)
Early sampling improves voriconazole target attainment in pediatric patients dosed with model-informed precision dosing tools: a simulation study
Dominic Tong
Favorite
Toukam, Marie
Biogen
(
S-115
)
Population PK/PD Modeling to Optimize Dosing of BIIB107, an Anti-Alpha-4 Integrin Monoclonal Antibody
Marie Toukam
Favorite
Trogdon, Michael
Pfizer
(
T-076
)
Virtual clinical trial simulations across treatment lines using a QSP model of CDK inhibitors in breast cancer patients
Michael Trogdon
Favorite
Tse, Andy
Bicycle Therapeutics
(
M-089
)
Identifying an optimal dose range for clinical development of BT7480 using a fit-for-purpose quantitative system pharmacology (QSP) modeling
Andy Tse
Favorite
Tummala, Hari Prabhath
University of Michigan, Ann Arbor
(
S-109
)
Mixed Effects Modeling of Diurnal Cortisol Dysregulation in Long COVID
Hari Prabhath Tummala
Favorite
Twarogowska, Monika
Simulations Plus
(
S-057
)
mlxDesignEval: A novel R package for design evaluation based on MonolixSuite, and its comparison to popED and PFIM
Monika Twarogowska
Favorite
